VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
USPHU.S. Physical Therapy, Inc.
$68.78$1.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksUSPHBalance Sheet

U.S. Physical Therapy, Inc. (USPH) Balance Sheet

30Y historyFree accessUpdated daily

The company's financial profile shows increasing leverage, with total debt rising to $362.8 million in 2026Q1, pushing the debt-to-equity ratio to 0.46.

USPH Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets139.11M139.99M137.58M233.38M111.27M95.17M87.64M85.39M79.21M77.08M65.96M60.18M54.85M49.66M45.32M45.67M39.28M32.84M38.72M36.03M35.98M36.85M40.61M33.02M23.08M22.41M13.74M14.65M15.6M14M11.8M
Cash & Short-Term Investments28.44M35.57M41.36M152.82M31.59M28.57M32.92M23.55M23.37M21.93M20.05M15.78M14.27M12.9M11.67M9.98M9.18M6.43M10.11M7.98M11.45M15M20.55M16.82M7.61M8.12M2.07M4.03M6.3M5.6M4.9M
Cash Only28.44M35.57M41.36M152.82M31.59M28.57M32.92M23.55M23.37M21.93M20.05M15.78M14.27M12.9M11.67M9.98M9.18M6.43M10.11M7.98M10.95M15M20.55M16.82M7.61M8.12M2.07M4.03M6.3M5.6M4.9M
Short-Term Investments00000000000000000000500K0000000000
Accounts Receivable96.72M64.25M85.67M51.87M68.61M62.42M50.95M56.05M51.49M50.36M41.49M38.62M34.59M32.66M27.68M29.95M26.37M23.63M26.75M26.72M22.28M20.42M18.22M14.4M13.68M13.65M11.15M9.99M8.7M7.9M6.5M
Days Sales Outstanding45.3730.0346.5831.345.2746.0243.9642.4541.4144.442.4742.5541.3945.1540.0746.1245.5642.8252.0264.3160.1556.4256.2149.7952.761.5464.3973.0172.1774.3273.68
Inventory0000000000000000000000000000000
Days Inventory Outstanding-------------------------------
Other Current Assets13.95M40.17M10.55M28.68M11.07M4.18M3.77M5.79M11.1M10.44M7.08M8.19M7.69M5.94M7.68M7.35M3.74M2.96M1.86M1.33M2.25M1.43M1.83M1.8M1.79M646K519K630K600K500K400K
Total Non-Current Assets1.1B1.06B1.03B763.86M746.89M654.26M506.73M475.46M363.95M341.9M285.27M219.73M189.7M174.47M126.39M117.58M101.58M78.41M79.53M60.22M35.48M29.67M21M19.45M17.95M13.77M9.23M8.7M8.5M8.5M7.7M
Property, Plant & Equipment187.82M271.07M166.08M129.53M127.75M119.41M103.26M103.68M20.17M20.39M19.17M16.65M15.76M14.96M13.02M13.19M13.92M14.34M15.84M16.79M13.37M13.74M13.65M11.81M10.41M7.8M6.99M6.49M6.4M6M6M
Fixed Asset Turnover3.47x2.88x4.04x4.67x4.33x4.15x4.10x4.65x22.51x20.31x18.60x19.89x19.35x17.65x19.37x17.97x15.17x14.05x11.85x9.03x10.11x9.62x8.67x8.94x9.10x10.37x9.04x7.70x6.88x6.47x5.37x
Goodwill715.87M692.39M667.15M509.57M494.1M434.68M345.65M317.68M293.52M271.34M226.81M171.55M147.91M143.96M100.19M92.75M79.42M57.25M55.89M37.65M21M0000000000
Intangible Assets179.82M172.86M179.31M109.68M108.75M86.38M56.28M52.59M48.83M48.95M38.06M30.3M24.91M14.48M12.15M9.6M7.31M5.96M6.45M3.93M014.34M6.13M5.68M5.59M4.52M897K948K1M1.2M800K
Long-Term Investments49.33M12.28M12.19M12.26M12.13M12.21M00-2.48M-2.06M-2.54M-2.35M0000000000000000000
Other Non-Current Assets6.99M-84.58M5.16M2.82M4.15M1.58M1.54M1.52M1.43M1.22M1.23M1.23M1.11M1.08M1.04M2.04M922K869K1.35M1.85M1.11M1.59M1.23M1.96M1.95M1.45M1.34M1.26M1.1M1.3M900K
Total Assets1.24B1.2B1.17B997.24M858.15M749.43M594.36M560.85M443.17M418.98M351.23M279.91M244.55M224.13M171.71M163.25M140.86M111.25M118.25M96.25M71.46M66.52M61.61M52.47M41.03M36.18M22.97M23.35M24.1M22.5M19.5M
Asset Turnover0.58x0.65x0.58x0.61x0.64x0.66x0.71x0.86x1.02x0.99x1.02x1.18x1.25x1.18x1.47x1.45x1.50x1.81x1.59x1.58x1.89x1.99x1.92x2.01x2.31x2.24x2.75x2.14x1.83x1.72x1.65x
Asset Growth %39.94%3.13%17.07%16.21%14.51%26.09%5.98%26.55%5.77%19.29%25.48%14.46%9.11%30.53%5.18%15.9%26.61%-5.91%22.85%34.7%7.42%7.97%17.41%27.88%13.4%57.53%-1.61%-3.13%7.11%15.38%22.64%
Total Current Liabilities117.3M139.04M116.28M102.19M85.49M83.48M93.49M60.56M41.95M39.55M24.62M19.01M25.5M23.17M16.31M16.32M14.23M14.59M14.61M11.44M9.17M7.12M5.62M5.42M2.85M3.25M3.32M2.16M2.6M2.8M2.6M
Accounts Payable6.76M6.06M5.94M3.9M6.5M6.47M1.33M2.49M2.02M2.17M1.63M1.64M1.78M1.72M1.73M1.81M1.24M1.29M1.48M1.55M1.6M1.72M1.18M498K624K539K434K349K600K300K300K
Days Payables Outstanding4.113.553.962.945.386.251.482.462.092.442.172.362.843.153.343.832.973.223.864.965.886.535.052.443.533.583.693.747.114.014.95
Short-Term Debt53.58M52M11M7.69M7.86M830K4.9M728K1.43M4.04M1.23M775K883K825K459K433K250K1.01M1.38M812K562K244K70K2.37M4K701K912K39K0100K100K
Deferred Revenue (Current)0000000002.83M0000000-175K0000002.19M1.9M00000
Other Current Liabilities56.96M80.98M022.49M000016.77M9.52M11.19M5.71M5.61M6.57M2.85M4.01M3.75M3.33M5.25M4.17M4.76M3.01M0033K-445K1.98M1.77M2M2.4M2.2M
Current Ratio1.19x1.01x1.18x2.28x1.30x1.14x0.94x1.41x1.89x1.95x2.68x3.17x2.15x2.14x2.78x2.80x2.76x2.25x2.65x3.15x3.92x5.18x7.23x6.09x8.10x6.90x4.14x6.79x6.00x5.00x4.54x
Quick Ratio1.19x1.01x1.18x2.28x1.30x1.14x0.94x1.41x1.89x1.95x2.68x3.17x2.15x2.14x2.78x2.80x2.76x2.25x2.65x3.15x3.92x5.18x7.23x6.09x8.10x6.90x4.14x6.79x6.00x5.00x4.54x
Cash Conversion Cycle41.25------------------------------
Total Non-Current Liabilities341.89M294.77M292.14M242.81M288.1M213.5M90.9M120.83M50.4M70.46M68.74M58.95M44.46M45.84M20.75M25.35M10.25M4.44M15.81M9.76M2.9M2.9M2.5M429K2.62M3.02M7.23M8.09M8.2M8.1M8.3M
Long-Term Debt194.04M263.17M142.53M138.99M175.83M117.59M16.6M50.36M38.4M56.73M50.6M48.34M34.73M40.65M17.57M23.78M5.75M400K12.41M7.96M797K483K083K2.35M3.02M7.23M8.09M8.1M8.2M8.3M
Capital Lease Obligations436.24M110.57M101.87M76.65M77.93M74.19M61.98M60.26M00000000000000000000000
Deferred Tax Liabilities129.26M28.39M29.46M24.82M21.3M14.38M7.78M10.07M9.01M10.88M15.74M9.22M0000000000000000000
Other Non-Current Liabilities1.86M-107.36M18.27M2.36M13.03M7.34M4.54M141K12M13.73M18.14M1.4M9.72M5.19M3.17M623K3.53M3.01M3.4M1.8M2.1M2.42M2.5M346K273K000100K-100K0
Total Liabilities459.19M433.81M408.42M345M373.59M296.98M184.39M181.39M92.35M110.01M93.35M77.96M69.96M69.01M37.05M41.67M24.48M19.03M30.43M21.2M12.07M10.02M8.12M5.85M5.47M6.27M10.55M10.24M10.8M10.9M10.9M
Total Debt362.83M425.74M295.23M258.59M295.34M223.08M110.99M137.83M39.84M60.77M51.82M49.11M35.62M41.48M18.03M24.22M6M1.41M13.79M8.77M1.36M727K70K2.46M2.35M3.72M8.14M8.13M8.1M8.3M8.4M
Net Debt334.39M390.17M253.87M105.76M263.74M194.51M78.07M114.28M16.47M38.84M31.78M33.33M21.35M28.58M6.36M14.23M-3.18M-5.02M3.68M795K-9.59M-14.28M-20.48M-14.37M-5.26M-4.4M6.07M4.1M1.8M2.7M3.5M
Debt / Equity0.46x0.55x0.39x0.40x0.61x0.49x0.27x0.36x0.11x0.20x0.20x0.24x0.20x0.27x0.13x0.20x0.05x0.02x0.16x0.12x0.02x0.01x0.00x0.05x0.07x0.12x0.66x0.62x0.61x0.72x0.98x
Debt / EBITDA3.32x4.14x3.61x3.82x4.13x2.71x1.76x1.78x0.57x0.94x0.89x0.89x0.68x0.94x0.42x0.59x0.15x0.04x0.46x0.35x0.06x0.03x0.00x0.12x0.11x0.19x0.64x0.87x1.07x1.24x1.58x
Net Debt / EBITDA3.06x3.79x3.10x1.56x3.69x2.37x1.24x1.47x0.24x0.60x0.54x0.60x0.41x0.64x0.15x0.34x-0.08x-0.15x0.12x0.03x-0.42x-0.62x-1.01x-0.70x-0.24x-0.23x0.48x0.44x0.24x0.40x0.66x
Interest Coverage8.24x9.23x8.51x6.31x10.62x78.70x41.09x35.11x30.49x2.60x4.32x6.54x6.14x72.08x68.96x74.34x143.12x80.28x44.53x66.56x---89.64x87.79x63.71x13.31x9.99x7.86x-5.14x
Total Equity782.87M769.74M759.05M652.24M484.57M452.44M409.97M379.45M350.82M308.97M257.88M201.95M174.59M155.12M134.66M121.58M116.38M92.22M87.82M75.06M59.39M56.5M53.49M46.63M35.56M29.91M12.42M13.1M13.3M11.6M8.6M
Equity Growth %35.48%1.41%16.38%34.6%7.1%10.36%8.04%8.16%13.54%19.81%27.69%15.67%12.55%15.2%10.76%4.47%26.19%5.01%17.01%26.38%5.11%5.63%14.72%31.11%18.87%140.84%-5.2%-1.48%14.66%34.88%45.76%
Book Value per Share51.6250.7250.3945.9737.3235.0831.9429.7527.7024.5820.6316.3014.2912.8411.3110.159.807.817.296.415.084.694.333.882.812.331.161.331.231.070.81
Total Shareholders' Equity468.98M476.43M488.93M476.19M315.79M295.61M276.16M240.26M215.94M204.87M187.55M162.78M146.28M128.29M117.32M107.05M103.96M87.35M81.61M69.41M55.52M53.48M50.18M43.35M32.54M26.67M9.56M10.72M11.6M10M7.6M
Common Stock175K174K172K172K152K151K151K150K149K148K147K146K145K143K141K139K139K138K142K141K137K136K134K122K118K107K57K36K000
Retained Earnings216.88M227.22M227.26M223.77M232.95M224.4M212.01M184.35M167.4M162.41M150.34M149.02M134.19M119.21M111.32M102.41M89.88M81.21M69.45M59.44M50.7M44.41M35.62M28.94M21.61M13.12M6.05M2.31M-100K-1.7M-4.1M
Treasury Stock-37.19M-37.19M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-26.11M-18.11M-12.52M-12.5M-1.99M-47K-47K000
Accumulated OCI978K714K2.8M2.78M4M000-64.15M-60.48M-56.02M-53.26M-49.05M0-44.16M-42.3M-39.23M-36.65M-33.17M-29.34M-25.57M-23.82M-23.04M-19.55M-16.69M-13.8M-11.46M-3.45M-7.6M-6M-4.3M
Minority Interest313.9M293.31M270.12M176.04M168.78M156.84M133.81M139.19M134.87M104.1M70.33M39.17M28.31M26.83M17.34M14.53M12.43M4.87M6.21M5.65M3.87M3.02M3.31M3.28M3.02M3.25M2.86M2.38M1.7M1.6M1M

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Goodwill impairment and leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Expansion Outpacing Cash Reserves

According to recent financial statements, USPH has seen total assets grow to $1.2 billion by 2026Q1, yet this expansion is increasingly funded by debt rather than internal cash accumulation, signaling a shift toward a more aggressive, leverage-dependent growth trajectory that warrants close monitoring by institutional investors.

The company's asset base has remained relatively static at $1.2 billion over the last five quarters, masking a significant underlying shift in composition toward higher goodwill and PPE. This suggests that the firm is prioritizing inorganic expansion through acquisitions, which may be necessary to offset organic volume stagnation but introduces execution risk regarding the integration of these new clinical assets.

Leverage Rising Amid Acquisition Activity

As reported in quarterly filings, USPH's total debt climbed to $362.8 million in 2026Q1 from a low of $254.3 million in 2024Q3, pushing the debt-to-equity ratio to 0.46 and indicating that the company is increasingly utilizing external financing to fund its ongoing clinic acquisition strategy.

While a debt-to-equity ratio of 0.46 remains manageable within the healthcare services sector, the upward trend in leverage suggests that the company's internal cash generation may be insufficient to support its desired pace of expansion. Investors should consider whether this increased reliance on debt will constrain future financial flexibility, particularly if reimbursement headwinds continue to pressure operating margins.

Goodwill Concentration Risks Asset Quality

Based on the latest balance sheet data, goodwill has ballooned to $715.9 million as of 2026Q1, representing a significant portion of the $1.2 billion total asset base, which suggests that the company's valuation is increasingly sensitive to the long-term performance of its acquired clinical partnerships.

The high concentration of intangible assets relative to tangible PPE reflects the premium paid for clinic acquisitions and the underlying partnership model. This composition implies that any sustained decline in the profitability of these acquired clinics could necessitate significant impairment charges, potentially impacting the company's book value and overall financial health.

Cash Buffer Tightening Under Pressure

According to reported figures, USPH's cash position has dwindled to $28.4 million in 2026Q1, down sharply from the $152.8 million held in 2023Q4, which indicates a narrowing liquidity buffer as the company aggressively deploys capital toward acquisitions and operational requirements.

The current ratio of 1.19 suggests that while the company maintains sufficient short-term liquidity to meet its immediate obligations, the significant reduction in cash reserves limits its ability to absorb unexpected operational shocks. This trend warrants further investigation into whether the company's working capital management is becoming overly strained by its current growth-at-all-costs strategy.

USPH — Frequently Asked Questions

Quick answers to the most common questions about buying USPH stock.

What are the total assets of U.S. Physical Therapy, Inc. (USPH)?

As of 2025, U.S. Physical Therapy, Inc. (USPH) had total assets of $1.20B including $140.0M in current assets.

How much debt does U.S. Physical Therapy, Inc. (USPH) have?

U.S. Physical Therapy, Inc. (USPH) carries total debt of $425.7M, offset by $35.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of U.S. Physical Therapy, Inc.?

U.S. Physical Therapy, Inc. (USPH) has total shareholders' equity (book value) of $476.4M ($50.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is U.S. Physical Therapy, Inc.'s current ratio and liquidity?

U.S. Physical Therapy, Inc. (USPH) reported a current ratio of 1.01x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.